E-LIB Suche - Ergebnisse für: Conte, P

1

Prognostic value of HER2DX in early-stage HER2-positive bre..:

Villacampa, G. ; Pascual, T. ; Brasó-Maristany, F....
ESMO Open. 9 (2024) 3 - p. 102388 , 2024

2

Vegan and sugar-substituted chocolates: assessing physicoch..:

Torregrossa, F. ; Cinquanta, L. ; Albanese, D....
European Food Research and Technology. 250 (2024) 4 - p. 1219-1228 , 2024

Link: https://doi.org/10.1007/..

3

An automatic L1-based regularization method for the analysi..:

Landi, G. ; Spinelli, G.V. ; Zama, F....
Applied Mathematics and Computation. 444 (2023) - p. 127809 , 2023

Link: https://doi.org/10.1016/..

4

OA21.06 ctDNA Dynamics, Prognostic Markers and Resistance M..:

Le, X. ; Garassino, M.C. ; Ahn, M.-J....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S94-S95 , 2023

Link: https://doi.org/10.1016/..

5

External fixator‐assisted plating osteosynthesis in a rabbi..:

Vandenbulcke, F. ; Anzillotti, G. ; Ravasio, G....
Journal of Experimental Orthopaedics. 10 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

6

METex14 ctDNA Dynamics & Resistance Mechanisms Detected in ..:

Paik, P. ; O'Hara, R. ; Veillon, R....
International Journal of Radiation Oncology*Biology*Physics. 112 (2022) 2 - p. e13-e14 , 2022

Link: https://doi.org/10.1016/..

7

Measuring hydrological connectivity inside soils with diffe..:

Conte, P. ; Ferro, V.
CATENA. 209 (2022) - p. 105848 , 2022

Link: https://doi.org/10.1016/..

8

The impact of COVID-19 on cancer care and oncology clinical..:

Sessa, C. ; Cortes, J. ; Conte, P....
ESMO Open. 7 (2022) 1 - p. 100339 , 2022

Link: https://doi.org/10.1016/..

9

Drug-induced interstitial lung disease during cancer therap..:

Conte, P. ; Ascierto, P.A. ; Patelli, G....
ESMO Open. 7 (2022) 2 - p. 100404 , 2022

Link: https://doi.org/10.1016/..

10

Residual Risk of Relapse: a Systematic Review and a Consens..:

Miglietta, F. ; Pronzato, P. ; Girardi, F....
European Journal of Cancer. 175 (2022) - p. S57-S58 , 2022

Link: https://doi.org/10.1016/..

11

T-DM1 versus pertuzumab, trastuzumab and a taxane as first-..:

Schettini, F. ; Conte, B. ; Buono, G....
ESMO Open. 6 (2021) 2 - p. 100099 , 2021

Link: https://doi.org/10.1016/..

12

Skip pattern approach toward the early access of innovative..:

Apolone, G. ; Ardizzoni, A. ; Biondi, A....
ESMO Open. 6 (2021) 4 - p. 100227 , 2021

Link: https://doi.org/10.1016/..

13

Druggable targets meet oncogenic drivers: opportunities and..:

Danesi, R. ; Fogli, S. ; Indraccolo, S....
ESMO Open. 6 (2021) 2 - p. 100040 , 2021

Link: https://doi.org/10.1016/..

14

Nutritional and aroma improvement of gluten-free bread: is ..:

Conte, P. ; Del Caro, A. ; Urgeghe, P.P....
LWT. 118 (2020) - p. 108711 , 2020

Link: https://doi.org/10.1016/..

15

Time course and management of key adverse events during the..:

Rugo, H.S. ; André, F. ; Yamashita, T....
Annals of Oncology. 31 (2020) 8 - p. 1001-1010 , 2020

Link: https://doi.org/10.1016/..